Clinical Trials Insight: 700036933
Latest Information Update: 09 Sep 2008
At a glance
- Drugs IMO 2134 (Primary)
- Indications Cancer
- Focus Adverse reactions
- Sponsors Novartis
Most Recent Events
- 09 Sep 2008 New trial record.
Latest Information Update: 09 Sep 2008